Study Indications

---

 Research aimed to further understand and treat neurodegenerative diseases such as Alzheimer’s and Parkinson’s Disease. 

 Latest research and new treatments for liver disease such as Non-alcoholic Steatohepatitis (NASH) and Non-alcoholic fatty liver disease (NAFLD). 

This includes metabolic syndrome, metabolic disorders and prediabetes. Symptoms of metabolic diseases range from insulin resistance, hypertension to a high body mass index and the inability to lose weight. 

 Studies range from genetic and molecular studies of the mechanisms of cardiovascular disease to studies of vascular properties, lifestyle interventions, and responsiveness to preventive pharmacotherapy. 

 In the United States, the most common endocrine disease is diabetes. There are many others such as Addison’s Disease, Cushing’s Syndrome, Graves’ Disease and Hashimoto’s Thyroiditis to consider clinical trial participation. 

 Clinical trials that are conducted to find better tests or procedures for diagnosing a particular disease or condition. 

Innovative research uses biomarkers to aid in diagnosis or monitoring and provide insight into “personalized” medicine. A biomarker is a quantifiable biological parameter (such as blood pressure, heart rate, blood and genetic test, and x-rays) that are measured and evaluated over time as an indicator of normal biological or pharmacologic responses to a therapeutic intervention. 

 Digestive diseases research for disorders of the digestive tract, which is sometimes called the gastrointestinal (GI) tract such as Gastroesophageal Reflux Disease (GERD), Crohn's Disease Ulcerative Colitis (UC). Irritable Bowel Syndrome (IBS) and Diverticulitis.